Skip to content

Relmada Therapeutics, Inc. RLMD Issuance Of Restricted Common Stock

Issuance Of Restricted Common Stock at other companies

Sharplink, Inc.
 logo
Sharplink, Inc. SBET
$572.5K+410%
Hut 8 Mining Corp. logo
Hut 8 Mining Corp.HUT
$2K0.0%
Atmos Energy logo
Atmos EnergyATO
$671.25K+22.2%
Mistras Group logo
Mistras GroupMG
-$1.61M-8.7%
Deckers Outdoor Corporation logo
Deckers Outdoor CorporationDECK
$2.28M+5.3%
Western Alliance Bancorporation logo
Western Alliance BancorporationWAL
$9M-41.6%

Other financials

Income statement

See full
Operating income-$19.5M-6.8%
Net income-$19.1M-8.5%
EPS (diluted)-$0.22+62.1%

Balance sheet

See full
Cash & equivalents$9.8M+750%
Total debt$104.1M-40.4%
Total equity$218.7M+875%
Total assets$235.4M+750%

Cash flow

See full
Operating cash flow-$15.1M+16.6%

Valuation

See full
Market cap$677.17M+2,907%

Returns & leverage

See full
Return on equity-48.8%-20.0pp
Debt / equity0.9×0.0×
Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept rlmd:IssuanceOfRestrictedCommonStock.

The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s issuance of restricted common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s issuance of restricted common stock?
Relmada Therapeutics, Inc. (RLMD) reported issuance of restricted common stock of $905.23K in Q1 2025.
What does issuance of restricted common stock mean?
The issuance of common stock subject to vesting or transfer restrictions, typically used as part of long-term incentive compensation plans. It tracks the dilution impact and the commitment of equity to key personnel.